Double-blind, randomized, controlled contraceptives, parallel group, to assess the effect on nerve fibers in patients diagnosed with endometriosis grade III / IV symptomatic ascending-dose oral quinagolide for 16 weeks Estudio doble ciego, aleatorizado, controlado con anticonceptivos, de grupos paralelos, para evaluar el efecto sobre las fibras nerviosas en pacientes diagnosticadas de endometriosis grado III/IV sintomática con quinagolida oral a dosis ascendentes durante 16 semanas

Trial Profile

Double-blind, randomized, controlled contraceptives, parallel group, to assess the effect on nerve fibers in patients diagnosed with endometriosis grade III / IV symptomatic ascending-dose oral quinagolide for 16 weeks Estudio doble ciego, aleatorizado, controlado con anticonceptivos, de grupos paralelos, para evaluar el efecto sobre las fibras nerviosas en pacientes diagnosticadas de endometriosis grado III/IV sintomática con quinagolida oral a dosis ascendentes durante 16 semanas

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jan 2013

At a glance

  • Drugs Quinagolide (Primary) ; Drospirenone
  • Indications Endometriosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top